Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer – a phase I study

BACKGROUND: Current approaches for the improvement of bNED for prostate cancer patients treated with radiotherapy mainly focus on dose escalation. However molecularly targeted approaches may also turn out to be of value. In this regard cyclooxygenase (COX)-2 inhibitors have been shown to exert some...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganswindt, U, Budach, W, Jendrossek, V, Becker, G, Bamberg, M, Belka, C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1464385/
https://www.ncbi.nlm.nih.gov/pubmed/16722607
http://dx.doi.org/10.1186/1748-717X-1-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1464385/
https://www.ncbi.nlm.nih.gov/pubmed/16722607
http://dx.doi.org/10.1186/1748-717X-1-9

Ejemplares similares